Press Release Archive – Kalytera Therapeutics, Inc.

Recent Press Releases

December 30, 2016

Kalytera (formerly Santa Maria Petroleum Inc.) Closes Reverse Takeover Transaction

December 14, 2016

Kalytera Appoints Dr. Andrew Salzman as Chief Executive Officer

August 23, 2016

Kalytera Appoints Dr. Andrew Salzman as Chief Medical Officer

August 8, 2016

Kalytera to Study Genetic Markers of Osteoporosis in Patients with Prader-Willi Syndrome

July 20, 2016

Kalytera Presents New Data Demonstrating KAL671’s Ability to Prevent Bone Loss in a Prader-Willi Syndrome Animal Model

July 5, 2016

Kalytera to Present New Data that Supports the Continued Investigation of KAL671 for the Treatment of Osteoporosis in Prader-Willi Syndrome at the IPWSO Conference

June 29, 2016

Kalytera Appoints Robert Farrell as President and Chief Financial Officer

June 27, 2016

Kalytera Appoints Dr. Stuart Silverman as Senior Vice President of Medical Affairs

June 23, 2016

Kalytera Appoints Robert S. Langer to the Scientific Advisory Board

June 2, 2016

Kalytera Licenses Transdermal Drug Delivery Technology from Delivra Corp.

March 17, 2016

Kalytera and Ramot at Tel Aviv University to Study Novel Approach to Treating Osteogenesis Imperfecta

February 15, 2016

Dr. Raphael Mechoulam to Deliver Keynote Presentation at the 2016 CannaTech Conference

Browse by Year